2006
DOI: 10.1107/s1600536806005101
|View full text |Cite
|
Sign up to set email alerts
|

Sumatriptan, an antimigraine drug

Abstract: Sumatriptan, {3‐[2‐(dimethyl­amino)eth­yl]‐1H‐indol‐5‐yl}‐N‐methyl­methane­sulfonamide, C14H21N3O2S, is reported in its parent form. The mol­ecular geometry is similar to that of sumatriptan succinate, but the two differ in their side‐chain orientations. Inter­molecular N—H⋯O and N—H⋯N hydrogen bonds form a glide‐symmetric chain along the c axis.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
5

Citation Types

1
6
0

Year Published

2007
2007
2016
2016

Publication Types

Select...
6

Relationship

3
3

Authors

Journals

citations
Cited by 7 publications
(7 citation statements)
references
References 7 publications
1
6
0
Order By: Relevance
“…From an overall perspective, the molecular geometry of (I) ( Table 1) is in good agreement with that of sumatriptan, (II) (Ravikumar et al, 2006). Both side chains are folded in the same direction, giving the molecule a cup-like appearance, with the planar indole ring system occupying the base.…”
Section: Commentsupporting
confidence: 52%
“…From an overall perspective, the molecular geometry of (I) ( Table 1) is in good agreement with that of sumatriptan, (II) (Ravikumar et al, 2006). Both side chains are folded in the same direction, giving the molecule a cup-like appearance, with the planar indole ring system occupying the base.…”
Section: Commentsupporting
confidence: 52%
“…By decreasing the width of blood vessels in the brain, rizatriptan relieves the pain of migraine headaches (Teall et al, 1998). The present study is a continuation of our ongoing programme on the structural elucidation of drug molecules [sumatriptan succinate (Ravikumar et al, 2004), sumatriptan (Ravikumar et al, 2006) and zolmitriptan (Ravikumar et al, 2007)].…”
Section: Commentmentioning
confidence: 83%
“…Frovatriptan is currently marketed as the monosuccinate salt monohydrate, Frova, by Vernalis partner Endo Pharmaceuticals Inc., USA. In continuation of our crystallographic studies on triptans (Ravikumar et al, 2004(Ravikumar et al, , 2006(Ravikumar et al, , 2007a(Ravikumar et al, ,b, 2008a, we describe herein the crystal structures of frovatriptan with acetic acid, (I), and succinic acid, (II) and (III).…”
Section: Commentmentioning
confidence: 99%